Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-18

Clinical Trial Update: The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of Leptin A-200, caffeine/ephedrine, and their combination on weight loss and body composition in men with obe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine/Ephedrine
  • Leptin A-200

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Obesity | NA | Status: COMPLETED